A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients ...

People with ulcerative colitis, a form of IBD, who were taking the new drug Omvoh and achieved clinical remission after 1 ...

Crohn's disease and ulcerative colitis. Here's how to tell which one you have.

Abivax SA ADR (NASDAQ:ABVX) shares climbed 7.7% in premarket trading Monday after the clinical-stage biotechnology company ...

The US Food and Drug Administration (FDA) has approved AbbVie’s supplemental new drug application, updating the indication ...

Eli Lilly’s ulcerative colitis (UC) treatment, Omvoh (mirikizumab), has shown sustained positive outcomes in patients with ...

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy now. On October 7, Eli Lilly and Company announced ...

The updated indication for the JAK inhibitor allows use in patients with moderately to severely active ulcerative colitis and Crohn’s disease after one systemic therapy if TNF blockers are inadvisable ...

The FDA has approved an updated indication for upadacitinib (Rinvoq; AbbVie) in inflammatory bowel disease (IBD), allowing its use in adults with moderately to severely active ulcerative colitis or ...

Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ...

You were just diagnosed with ulcerative colitis. Now what? Here, gastroenterologists share the 7 questions to ask your doctor ...

Microscopic colitis is a lifelong condition that causes symptoms such as diarrhea and abdominal pain. It is a type of inflammatory bowel disease (IBD). While there is no cure for microscopic colitis, ...